BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1985689)

  • 21. Nonspecific rheological abnormalities in sickle cell disease.
    Schmid-Schönbein H; Heidtmann H
    Blood Cells; 1982; 8(1):89-101. PubMed ID: 7115981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of blood rheology in sickle cell disease.
    Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
    Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins.
    Middelkoop E; Lubin BH; Bevers EM; Op den Kamp JA; Comfurius P; Chiu DT; Zwaal RF; van Deenen LL; Roelofsen B
    Biochim Biophys Acta; 1988 Jan; 937(2):281-8. PubMed ID: 3337804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Noomuna P; Risinger M; Zhou S; Seu K; Man Y; An R; Sheik DA; Wan J; Little JA; Gurkan UA; Turrini FM; Kalfa T; Low PS
    Br J Haematol; 2020 Aug; 190(4):599-609. PubMed ID: 32346864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptation of the ektacytometer to automated continuous pO2 changes: determination of erythrocyte deformability in sickling disorders.
    Bessis M; Feo C; Jones E; Nossal M
    Cytometry; 1983 Jan; 3(4):296-9. PubMed ID: 6822150
    [No Abstract]   [Full Text] [Related]  

  • 27. Deformability of oxygenated irreversibly sickled cells.
    Clark MR; Mohandas N; Shohet SB
    J Clin Invest; 1980 Jan; 65(1):189-96. PubMed ID: 7350198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane phospholipid organization in pathologic human erythrocytes.
    Lubin B; Chiu D
    Prog Clin Biol Res; 1982; 97():137-50. PubMed ID: 7156165
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathophysiology of abnormal cell volume in human red cells.
    Ellory JC; Gibson JS; Stewart GW
    Contrib Nephrol; 1998; 123():220-39. PubMed ID: 9761971
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red cell.
    Sugihara T; Repka T; Hebbel RP
    J Clin Invest; 1992 Dec; 90(6):2327-32. PubMed ID: 1469090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (second of three parts).
    Dean J; Schechter AN
    N Engl J Med; 1978 Oct; 299(15):804-11. PubMed ID: 692564
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease.
    Nash GB; Johnson CS; Meiselman HJ
    Blood; 1984 Jan; 63(1):73-82. PubMed ID: 6689955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheological and adherence properties of sickle cells. Potential contribution to hematologic manifestations of the disease.
    Mohandas N; Evans E
    Ann N Y Acad Sci; 1989; 565():327-37. PubMed ID: 2672968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Erythrocyte adhesion to vascular endothelium: clinical applications].
    Chaudet B; Renard M; Seigneur M; Boisseau MR
    Rev Med Interne; 2000 Jul; 21(7):599-607. PubMed ID: 10942976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesiculation of sickle erythrocytes during thermal stress.
    Rank BH; Moyer NL; Hebbel RP
    Blood; 1988 Sep; 72(3):1060-3. PubMed ID: 3416068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomic nervous system dysfunction: implication in sickle cell disease.
    Connes P; Coates TD
    C R Biol; 2013 Mar; 336(3):142-7. PubMed ID: 23643396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sickle cell anemia as a rheologic disease.
    Horne MK
    Am J Med; 1981 Feb; 70(2):288-98. PubMed ID: 7008586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of spicules obtained from sickle red cells on clotting activity.
    Westerman MP; Cole ER; Wu K
    Br J Haematol; 1984 Apr; 56(4):557-62. PubMed ID: 6424699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endothelium and sickle cell anemia, or how an amino acid mutation disturbs blood circulation].
    Wautier JL
    Rev Prat; 1999 Jan; 49(2):121-3. PubMed ID: 9989145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.